Back to Journals » OncoTargets and Therapy » Volume 1

Review

Refining targeted therapies in chronic myeloid leukemia: development and application of nilotinib, a step beyond imatinib

       
Total article views   HTML views PDF downloads Totals
6,486 Dovepress* 6,486+ 1,761 8,247
Totals 6,486 1,761 8,247
*Since 17 October 2008
+Since July 2016

View citations on Google Scholar